白血球除去、白血球アフェレーシス、白血球搬出法
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/04/27 05:17:32」(JST)
[Wiki en表示]
Leukapheresis |
Intervention |
ICD-10-PCS |
6A550Z1, 6A551Z1 |
MeSH |
D007937 |
OPS-301 code |
8-802 |
[edit on Wikidata]
|
Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis, the more general term for separating out one particular constituent of blood and returning the remainder to the circulation.
Leukapheresis may be performed to decrease a very high white blood cell count, to obtain autologous (i.e., the patient's own) blood cells for later transplant back into the patient, or to obtain cells for research purposes. In the case of hematological malignancies such as acute leukemias, white blood cell counts may be high enough to cause hemostasis and "sludging" in the capillaries. This can affect retinal vasculature leading to vision changes, pulmonary vasculature leading to shortness of breath from decreased efficiency in oxygen exchange, as well as other organ systems such as the brain which would become clinically apparent with neurological deterioration of a patient from cerebrovascular compromise.
Leukapheresis may also be performed to obtain the patient's own blood cells for later transplant. White blood cells may be removed to protect them from damage before high-dose chemotherapy, then transfused back into the patient, in the treatment of advanced breast cancer.[1] Another novel use of cells obtained through leukapheresis is to stimulate a patient’s immune system to target prostate cancer cells.[2]
Alternatively, only granulocytes, macrophages and monocytes can be removed, leaving the lymphocyte count largely unchanged. This is used as a treatment for autoimmune diseases such as ulcerative colitis [3] and rheumatoid arthritis,[4] where these cells play an active part in the inflammation process.
Leukapheresis, typically for granulocytes, is a rarely performed blood donation process. The product is collected by automated apheresis and is used for systemic infections in patients with neutropenia. The donor is typically a blood relative who has received stimulating medications (a directed donation), and the product is irradiated to prevent GVHD. The product generally has a 24-hour shelf life from collection and is often transfused before infectious disease testing is completed. It is a therapy of last resort, and its use is controversial and rare.
References
- ^ Transfusion. 2003 Feb;43(2):259-64. Leukapheresis after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: a novel approach to harvest a second autograft. Schwella N, Braun A, Ahrens N, Rick O, Salama A.
- ^ Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer July 29, 2010Kantoff P.W., Higano C.S., Shore N.D., et al.N Engl J Med 2010; 363:411 - 422
- ^ * National Institute for Health and Clinical Excellence, Leukapheresis for inflammatory bowel disease (guidance). Retrieved Oct. 06 2005
- ^ | author = G Hahn, B Stuhlmüller, N Hain, J R Kalden, K Pfizenmaier, and G R Burmester | year = 1993 | pmc=288038 | title = Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy | journal = The Journal of Clinical Investigation | volume = 91 | pages = 862–70 | doi = 10.1172/JCI116307 | pmid = 8450066 | issue = 3
External links
- Circular of Information for Blood Products
Transfusion medicine
|
|
General concepts |
- Apheresis (plasmapheresis, plateletpheresis, leukapheresis)
- Blood transfusion
- Coombs test (direct and indirect)
- Cross-matching
- Exchange transfusion
- International Society of Blood Transfusion
- Intraoperative blood salvage
- ISBT 128
- Transfusion reactions
|
|
Blood group systems /
blood types |
- ABO
- Chido-Rodgers
- Colton
- Cromer
- Diego
- Dombrock
- Duffy
- Er
- FORS
- Gerbich
- GIL
- GLOB
- Hh
- Ii
- Indian
- JR
- JMH
- Kell (Xk)
- Kidd
- Knops
- Lan
- Lewis
- Lutheran
- LW
- MNS
- OK
- P
- Raph
- Rh and RHAG
- Scianna
- T-Tn
- Vel
- Xg
- Yt
- Other
|
|
Blood products /
blood donation |
- Whole blood
- Platelets
- Red blood cells
- Plasma / Fresh frozen plasma / PF24 (Cryoprecipitate + Cryosupernatant)
- Blood substitutes
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Successful continual intratympanic steroid injection therapy in a patient with refractory sensorineural hearing loss accompanied by relapsing polychondritis.
- Wasano K1, Tomisato S2, Yamamoto S2, Suzuki N3, Kawasaki T2, Ogawa K3.
- Auris, nasus, larynx.Auris Nasus Larynx.2017 Aug;44(4):489-492. doi: 10.1016/j.anl.2016.07.019. Epub 2016 Aug 20.
- PMID 27552828
- Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 109 /l. The NOPHO experience 1984-2014.
- Zeller B1, Glosli H1, Forestier E2, Ha SY3, Jahnukainen K4, Jónsson ÓG5, Lausen B6, Palle J7, Hasle H8, Abrahamsson J9; NOPHO AML working group.
- British journal of haematology.Br J Haematol.2017 May 25. doi: 10.1111/bjh.14692. [Epub ahead of print]
- PMID 28542715
- Clotting during autologous hematopoietic progenitor cells collection.
- Gokhale A1,2, Quraishy N1, Veemara V3, Howdyshell H3, Murray L3, Royer J3, Salmi L3, Ricci K3, Liu H3.
- Journal of clinical apheresis.J Clin Apher.2017 May 9. doi: 10.1002/jca.21539. [Epub ahead of print]
- PMID 28485035
Japanese Journal
- Heart rate variability during and after peripheral blood stem cell leukapheresis in autologous transplant patients and allogeneic transplant donors
- NAKANE Takahiko,NAKAMAE Hirohisa,KOH Hideo,NAKAMAE Mika,AIMOTO Ran,TERADA Yoshiki,KOH Ki-Ryang,YAMANE Takahisa,HINO Masayuki
- International journal of hematology 91(3), 478-484, 2010-04-15
- NAID 10026401362
- Safe And Efficient Collection of Cytokine-Mobilized Peripheral Blood Cells From Cynomolgus Monkeys (Macaca fascicularis) with Human Newborn-Equivalent Body Weights
- AGEYAMA Naohide,HANAZONO Yutaka,SHIBATA Hiroaki,ONO Fumiko,OGAWA Hiromi,NAGASHIMA Takeyuki,UEDA Yasuji,YOSHIKAWA Yasuhiro,HASEGAWA Mamoru,OZAWA Keiya,TERAO Keiji
- Experimental animals 54(5), 421-428, 2005-10-01
- Hematopoietic stem cells in bone marrow can be mobilized into peripheral blood by cytokine administration. Cytokine-mobilized peripheral blood stem cells are of great use in clinical applications. We …
- NAID 10016785510
Related Links
- leukapheresis /leu·ka·phe·re·sis/ (loo″kah-fĕ-re´sis) the selective separation and removal of leukocytes from withdrawn blood, the remainder of the blood then being retransfused into the donor. leu·ka·phe·re·sis (l k-f-r s s) n. The ...
- Leuko Pak 101: How Leukapheresis Products are Best Utilized in the Lab, Pronounce Medical Words ― Leukapheresis, How to Pronounce Leukapheresis, Dr. Michael Rotkowitz Explains the Sipuleucel-T Treatment Process ... The ...
★リンクテーブル★
[★]
- 英
- leukapheresis
- 関
- 白血球搬出法、白血球アフェレーシス
[★]
- 英
- leukapheresis
- 関
- 白血球アフェレーシス、白血球除去
[★]
- 英
- leukapheresis
- 関
- 白血球搬出法、白血球除去